ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
August 04, 2021Tenaya announced today the closing of its underwritten, upsized initial public offering of 13,800,000 shares of its common stock, which includes the exercise in full of the underwriters' option to purchase 1,800,000 additional shares of its common stock -
Tenaya Therapeutics Announces New Appointments to Leadership Team
July 01, 2021Tenaya Therapeutics, a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced the hires of Leone Patterson, MBA, as Chief Financial and Business Officer
Pharma Sources Insight January 2025
